<DOC>
	<DOC>NCT00100074</DOC>
	<brief_summary>To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.</brief_summary>
	<brief_title>To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1</brief_title>
	<detailed_description>The primary objective of this study is to characterize the pharmacokinetics of three ascending doses of lobeline in normal volunteers.</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>Healthy individuals with a body mass index between 18 and 30. Willing and able to give written consent. Must have a negative drug test Females must have a negative pregnancy test prior to study drug administration Must have no medical contraindications as determined by routine testing Please contact the site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2004</verification_date>
</DOC>